Bas Wiersma

Gilde Equity Management is a Private Equity firm founded in 1996. The firm is headquartered in Heemstede Estate, Netherlands.

Gilde Equity Management Benelux Partners BV provides investment services. The company is headquartered in Utrecht, the Netherlands.

Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain.

Gilde Healthcare Holding BV is an investment holding Dutch company. The private company is based in Utrecht, NL. and has subsidiaries in Australia, Netherlands, United States and Germany. The CEOs of the company are Edwin William de Graaf, Marc Olivier Perret.

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.

Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge.

Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.

Etablissements Oscar Tausig NV is a Belgian company that engages in trade brokerage in food and luxury goods. The private company is based in Braine-L'Alleud, Belgium. The company was founded in 1983. Davy de Muyer has been the CEO of the company since 2014.

Part of Actief Interim NV, Actief Holding NV provides temporary employment agency services. The company is based in Lummen, Belgium. The CEO of the Belgian company is Mark Maesen.

conTeyor Holding operates as a financial holding company with interests in packaging industry. The company was founded on April 29, 2010 and is headquartered in Merelbeke, Belgium.

International Spice & Food Import NV manufactures herbs and spices. Its activities include mixing and grinding, packaging, sourcing, retail and production. The firm offers paprika, anise, saffron, savory, green cardamom, mustered seeds, green paper and other different spice products. The company was founded by Anne-Marie Stevens and Christian Vanvaek in 1982 and is headquartered in Braine-l'Alleud, Belgium.

Rabobank International Holding BV operates as a holding company. It operates through subsidiaries, which offers credit banking services in rural areas for the cooperative and agricultural sectors. The company is headquartered in Utrecht, the Netherlands.

Tagworks Pharmaceuticals BV is a Dutch precision therapy company that develops a new standard of care for patients suffering from severe diseases, including cancer. Tagworks Pharmaceuticals is based in and the Netherlands. The company leverages its technology platform, which is protected by a broad patent estate, to pioneer the click-to-release approach. Tagworks is developing a pipeline of click-cleavable therapies, including its lead program, TGW101, an antibody-drug conjugate targeting TAG72. The company's technology enables on-target activation of ADCs and immunomodulators, as well as off-target deactivation of radioimmunotherapies to enhance their therapeutic index. The company was founded in 2011 by Raffaella Rossin, Zach Taylor, Marc Robillard, and Marc Robillard has been the CEO since 2011.